Selection of genetically modified cell population using hapten-specific antibody/receptor chimera
- 27 February 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 315 (1) , 132-138
- https://doi.org/10.1016/j.bbrc.2004.01.030
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Selection of highly productive mammalian cells based on an inducible growth advantage using an antibody/receptor chimeraJournal of Bioscience and Bioengineering, 2002
- Plat-E: an efficient and stable system for transient packaging of retrovirusesGene Therapy, 2000
- A G-CSF Receptor–Gyrase B Fusion Gene: A New Type of Molecular Switch for Expansion of Genetically Modified Hematopoietic CellsBiochemical and Biophysical Research Communications, 1999
- An antagonist peptide–EPO receptor complex suggests that receptor dimerization is not sufficient for activationNature Structural & Molecular Biology, 1998
- Functional Mimicry of a Protein Hormone by a Peptide Agonist: The EPO Receptor Complex at 2.8 ÅScience, 1996
- Functional Isolation and Characterization of Human Hematopoietic Stem CellsScience, 1995
- Complete protection of antisense oligonucleotides against serum nuclease degradation by an avidin-biotin systemBioconjugate Chemistry, 1992
- Antigen Responsive Antibody–Receptor Kinase ChimeraBio/Technology, 1992
- Effect of amplification ofdhfr andlac Z genes on growth and β-galactosidase expression in suspension cultures of recombinant CHO cellsCytotechnology, 1992
- IL3-dependent mouse clones that express B-220 surface antigen, contain ig genes in germ-line configuration, and generate B lymphocytes in vivoCell, 1985